Reaxa sets up Indian subsidiary

- Last updated on GMT

Related tags: India, Corporation, United kingdom

Reaxa will set up an Indian subsidiary to manage supply chain, commercial scale production and application development for its growing number of customers in the country.

The firm, which specialises in industrial catalysis with its EnCat immobilised technology, is launching Reaxa India using funds raised through investments by UK groups Enterprise Ventures and YFM Private Equity and India’s S Amit & Co.

S Amit & Co, which already sells Reaxa’s EnCat and QuadraPure technologies to customers in India, will begin commercial sales of its Nickel EnCat range in the country in the near future.

Reaxa sales director Ed Dutton said that sees Reaxa India as the next step towards establishing a commercial manufacturing presence in India.

Related news

Show more

Related products

The battle of performance in pharma production

The battle of performance in pharma production

Telstar Life Science Solutions | 26-Mar-2019 | Case Study

Telstar case study. Discover how a versatile freeze-dryer automatic loading & unloading systemDiscover how a versatile freeze-dryer automatic loading...

Accelerate your supply chain as pressures intensify

Accelerate your supply chain as pressures intensify

William Reed | 17-Sep-2018 | Technical / White Paper

Food, Drink and Non-Food manufacturers are under pressure. Range reviews, massive retail mergers, the backlash against plastic packaging and the ongoing...

Steridose

Optimizing vessel geometry for mag drive agitators

Steridose, Inc | 14-Sep-2017 | Technical / White Paper

The performance of a bottom mount magnetically driven agitator (mag drive mixer) is heavily dependent on its relationship with the vessel’s geometry, baffles,...

Related suppliers